Form 13-F position report

GLOBUS MED INC

Reported by GW&K Investment Management LLC

GMED CUSIP 379577208 Manager CIK 0001082917

Reported 1,472,542 shares, up 19,336 (1.3%) from the prior quarter.

Reported value -3.9%; share count 1.3% vs. the prior quarter.

Added
% of reported 13F value 0.93% This manager · Q3 2026
Shares 1,472,542 Quarter-end amount reported
Reported value $110,294,000 Fair value at quarter end
Consecutive quarters held 51 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 109230000
2022-03-31 113208000
2022-06-30 85567000
2022-09-30 93895000
2022-12-31 127161000
2023-03-31 96293000
2023-06-30 100570000
2023-09-30 82582000
2023-12-31 93789000
2024-03-31 93690000
2024-06-30 120536000
2024-09-30 125379000
2024-12-31 144338000
2025-03-31 125899000
2025-06-30 109170000
2025-09-30 101793000
2025-12-31 132392000
2026-03-31 128786000
2026-06-30 114818000
2026-09-30 110294000

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for GLOBUS MED INC held by GW&K Investment Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 1,472,542 +19,336 (1.3%) 0.93% $110,294,000 2026-11-10
Q2 2026 Reduced 1,453,206 -41,517 (-2.8%) 0.9% $114,818,000 2026-08-12
Q1 2026 Reduced 1,494,723 -21,622 (-1.4%) 1.14% $128,786,000 2026-05-13
Q4 2025 Reduced 1,516,345 -261,086 (-14.7%) 1.14% $132,392,000 2026-02-11
Q3 2025 Reduced 1,777,431 -72,271 (-3.9%) 0.9% $101,793,000 2025-11-12
Q2 2025 Added 1,849,702 +129,774 (7.5%) 0.98% $109,170,000 2025-08-11
Q1 2025 Reduced 1,719,928 -25,187 (-1.4%) 1.17% $125,899,000 2025-05-05
Q4 2024 Reduced 1,745,115 -7,457 (-0.4%) 1.23% $144,338,000 2025-02-05
Q3 2024 Reduced 1,752,572 -7,322 (-0.4%) 1.07% $125,379,000 2024-11-07
Q2 2024 Added 1,759,894 +13,241 (0.8%) 1.1% $120,536,000 2024-08-12
Q1 2024 Reduced 1,746,653 -13,330 (-0.8%) 0.83% $93,690,000 2024-05-08
Q4 2023 Added 1,759,983 +96,713 (5.8%) 0.87% $93,789,000 2024-02-09
Q3 2023 Reduced 1,663,270 -25,852 (-1.5%) 0.83% $82,582,000 2023-11-09
Q2 2023 Reduced 1,689,122 -10,973 (-0.6%) 0.95% $100,570,000 2023-08-09
Q1 2023 Reduced 1,700,095 -12,056 (-0.7%) 0.93% $96,293,000 2023-05-09
Q4 2022 Added 1,712,151 +135,935 (8.6%) 1.29% $127,161,000 2023-02-10
Q3 2022 Added 1,576,216 +52,041 (3.4%) 1.04% $93,895,000 2022-11-09
Q2 2022 Reduced 1,524,175 -10,230 (-0.7%) 0.92% $85,567,000 2022-08-09
Q1 2022 Added 1,534,405 +21,525 (1.4%) 1.01% $113,208,000 2022-05-09
Q4 2021 Added 1,512,880 +24,130 (1.6%) 0.91% $109,230,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

685 managers reported GLOBUS MED INC for Q3 2026.

Managers reporting GLOBUS MED INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 10,906,047 +99,323 0.01% $816,862,956 9 qtrs
JANUS HENDERSON GROUP PLC Added 8,634,195 +1,011,100 0.27% $646,722,089 1 qtr
VANGUARD CAPITAL MANAGEMENT LLC Reduced 5,075,559 -31,973 < 0.01% $380,159,369 3 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 4,866,366 -128,019 0.02% $364,490,813 3 qtrs
STATE STREET CORPORATION Added 3,718,553 +4,524 < 0.01% $278,519,620 54 qtrs
Boston Partners Added 3,415,554 +1,860,564 0.23% $255,897,564 2 qtrs
JPMorgan Chase & Co Added 3,158,516 +414,666 0.01% $239,549,935 49 qtrs
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Reduced 3,196,729 -1,083,001 0.9% $239,435,002 2 qtrs
DIMENSIONAL FUND ADVISORS LP Added 3,007,442 +638,132 0.04% $225,264,959 52 qtrs
Swedbank AB Added 2,880,843 +2,360,480 0.18% $215,775,142 11 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 10, 2026
Filing type
13F-HR
Position type
COMMON

Voting authority reported

Sole
1,380,039
Shared
91,937
None
566

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.